REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Adult Joint Formulary
Home > Formulary : Adult > Local Guidelines >

2. Cardiovascular System Guidelines

Anticoagulation Guidance

DOAC Decision Aid Tool for non-valvular AF - this document is currently being updated

Summary of considerations when prescribing a DOAC in non-valvular AF

BNSSG Guidance on switching between oral anticoagulants (July 2022)

BNSSG ICS Warfarin Counselling checklist

BNSSG ICS DOACs Counselling checklist

Shared decision making tool - Low dose Rivaroxaban plus aspirin for prevention of Cardiovascular events 

Management of Subtherapeutic INR in the community

Management of High INR in the community.

INR Self-testing Position Statement for BNSSG 

INR Self-testing Agreement for BNSSG

 

Renal Anticoagulant Guidelines:

NBT

UHBW

Anticoagulation Patient Information:

Warfarin:

BNSSG Warfarin Patient Information Leaflet 

DOACs:

National NHS & BSH DOAC Booklet 

Primary care - resources can be ordered from PCSE Online.

Secondary care -  resources can be ordered from NHS Forms.

Apixaban

Dabigatran 

Edoxaban

Rivaroxaban

 

BNSSG Community Pharmacy Specialist Medicines LES

 
A number of pharmacies across BNSSG are providing the local enhanced service for the 'Availability of Specialist Medicines', which includes enoxaparin (Inhixa brand) and Phytomenadione (vitamin K). By providing this, pharmacies are required to ensure that the specialist medicines are available at all times during their opening hours and on any bank or public holidays on which they open.
Pharmacies currently providing the service can be found here and the medication they hold can be found here. Please note the medication list may need to be revised as guidance and/or availability of medicines changes.
It is advised to always ring the pharmacy to check current stock and opening times or consult Find a Pharmacy - NHS for opening times.

 

Antiplatelet Guidance

BNSSG Guidelines for the Prescribing of Antiplatelets

 

Heart Failure Guidance

Primary Care Heart Failure Treatment Guideline

Practical Guidance on how to use Heart Failure Medications

Traffic light: How to monitor renal function and potassium rises in stable Heart Failure

Use of Dapagliflozin & Empagliflozin (SGLT2i) in Patients with Heart Failure

See Endocrine System Guidelines page for the 'Advice on the use of SGLT-2 inhibitors in Type 2 Diabetes, Heart Failure and Chronic Kidney Disease'

 

Hypertension

BNSSG Guideline for investigation and management of hypertension in Adults

 

Lipid Guidance

Combined BNSSG Lipid Guidelines

Inclisiran Information for Primary Care

 

For guidelines relating to appliances and devices, including hosiery and garments, see 20. Appliances and Part IX